These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2689957)

  • 21. Insulin-induced localized lipoatrophy.
    Breznik V; Kokol R; Luzar B; Miljković J
    Acta Dermatovenerol Alp Pannonica Adriat; 2013 Dec; 22(4):83-5. PubMed ID: 24336944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Injection site lipoatrophy: a rare complication of recombinant human insulin.
    Chakraborty PP; Bhattacharjee R
    J Assoc Physicians India; 2010 Oct; 58():630. PubMed ID: 21510114
    [No Abstract]   [Full Text] [Related]  

  • 23. Insulin injection lipoatrophy recidivus.
    Rosenbloom AL
    Pediatr Diabetes; 2014 Feb; 15(1):73-4. PubMed ID: 23763651
    [No Abstract]   [Full Text] [Related]  

  • 24. Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs.
    Radermecker RP; Piérard GE; Scheen AJ
    Am J Clin Dermatol; 2007; 8(1):21-8. PubMed ID: 17298103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lipoatrophy after insulin injections can be treated with lipofilling].
    Lund PS; Sjøstrand H; Matzen SH
    Ugeskr Laeger; 2016 Dec; 178(49):. PubMed ID: 27959262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical examination of diabetic patients treated with monocomponent insulin manufactured by MP Polfa].
    Orłowska-Kunikowska E; Horoszek-Maziarz S; Loss-Fisior R; Semetkowska-Jurkiewicz E; Dominiak K; Wójcikowski C
    Pol Tyg Lek; 1989 May 22-29; 44(21-22):503-6. PubMed ID: 2702341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Picture of the month: insulin-related lipoatrophy].
    Yazdanyar S; Dolmer B; Strauss G
    Ugeskr Laeger; 2011 Aug; 173(33):1968. PubMed ID: 21849139
    [No Abstract]   [Full Text] [Related]  

  • 28. Lipoatrophy induced by recombinant human insulin injection.
    Murao S; Hirata K; Ishida T; Takahara J
    Intern Med; 1998 Dec; 37(12):1031-3. PubMed ID: 9932635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Soft tumors in the mid abdomen and thighs. Diabetes, lipohypertrophy].
    Winter M
    MMW Fortschr Med; 2011 Oct; 153(43):5. PubMed ID: 22097618
    [No Abstract]   [Full Text] [Related]  

  • 30. [Education of the diabetic patient--insulin injection and lipodystrophy].
    Gilbert C
    Soins; 2000-2001 Dec-Jan; (651):23-5. PubMed ID: 11301548
    [No Abstract]   [Full Text] [Related]  

  • 31. Lipoatrophy induced by subcutaneous administration of octreotide in the treatment of acromegaly.
    Atmaca A; Erbas T
    Exp Clin Endocrinol Diabetes; 2005 Jun; 113(6):340-3. PubMed ID: 15977102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparative study between the subcutaneous continuous insulin infusion pump and optimized conventional treatment. Effects at 6 months].
    Goicolea Opacua I; Hernández Colau I; Vázquez García JA
    Rev Clin Esp; 1986 Jun; 179(1):3-7. PubMed ID: 3526432
    [No Abstract]   [Full Text] [Related]  

  • 33. Lipoatrophic diabetes mellitus treated by continuous subcutaneous insulin infusion.
    Meyer L; Hadjadj S; Guerci B; Delbachian I; Ziegler O; Drouin P
    Diabetes Metab; 1998 Dec; 24(6):544-6. PubMed ID: 9932222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Why pumps? Continuous subcutaneous insulin infusion for children and adolescents with type 1 diabetes.
    Weintrob N; Shalitin S; Phillip M
    Isr Med Assoc J; 2004 May; 6(5):271-5. PubMed ID: 15151365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
    Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
    Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Insulin portable pump vs. intensified conventional injections in diabetes].
    Gutman RA; Litwak LE; Fagin JA; Plantalech L; Steiner S
    Medicina (B Aires); 1985; 45(3):225-30. PubMed ID: 3915900
    [No Abstract]   [Full Text] [Related]  

  • 38. Hyperkalaemia, ketoacidosis and subcutaneous or intravenous insulin infusions.
    MacRury SM; Small M; MacCuish AC
    Diabetes Res; 1987 Jul; 5(3):153-5. PubMed ID: 3117474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipoatrophy associated with the use of insulin analogues: a new case associated with the use of insulin glargine and review of the literature.
    Holstein A; Stege H; Kovacs P
    Expert Opin Drug Saf; 2010 Mar; 9(2):225-31. PubMed ID: 20001763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reversal of insulin lipoatrophy by monocomponent insulin.
    Aw TC; Ee BK; Cheah JS
    Singapore Med J; 1978 Dec; 19(4):227-30. PubMed ID: 751208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.